Please login to read the full article.
Scrip Regulatory Affairs
New Zealand to improve ethics committee approval process for pharma trials
07 September 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Australian panel recommends transparency overhaul at TGA
- Govt committee makes recommendations for improving New Zealand's clinical trials environment
- US FDA consults on new framework for classifying significant drug post-market safety issues
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
